The adherence to the guidelines for assessing and treating Wernicke's encephalopathy in patients with alcohol withdrawal
Background: The current clinical approach to administering intravenous (IV) Pabrinex for patients admitted with alcohol withdrawal is based on the risk of Wernicke’s encephalopathy (WE). In patients at risk of WE, clinical features, such as ophthalmoplegia and nystagmus, are essential in determining...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Clinical Medicine |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S147021182500185X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|